Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets	idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder	Recruiting	Phase 3	2026-09-14		NCT07671911

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Trevi Therapeutics	3

19 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Anmed Medical Center	Anderson	United States	1
Clinical Research and Associates, Inc.	Miami	United States	1
Clinical Research Associates of Central, PA, LLC	DuBois	United States	1
Clinical Research of Gastonia (CRG)	Gastonia	United States	1
Clinical Research Specialists, Llc - Kissimmee	Kissimmee	United States	1
Coastal Pulmonary & Critical Care, PLC	St. Petersburg	United States	1
Critical Care Pulmonary and Sleep Associates (Ccpsa) - West Clinic	Lakewood	United States	1
El Paso Pulmonary Association, PA	El Paso	United States	1
Elevate Clinical Research	Houston	United States	3
Hannibal Regional Hospital	Hannibal	United States	2
Horizon Clinical Research Group	Cypress	United States	15
Meris Clinical Research	Brandon	United States	2
Newportnativemd, Inc.	Newport Beach	United States	1
Palmtree Clinical Research	Palm Springs	United States	2
Paradigm Clinical Research Centers, Inc. - Redding	Redding	United States	1
Pulmonary Associates of Richmond Inc (Par) - West Broad Location	Richmond	United States	1
Pulmonary Specialists of The Palm Beaches	Loxahatchee Groves	United States	1
Southeastern Research Center	Winston-Salem	United States	15
Tulane Clinic	New Orleans	United States	1